Search by Drug Name or NDC

    NDC 69315-0174-60 OSELTAMIVIR PHOSPHATE 6 mg/mL Details

    OSELTAMIVIR PHOSPHATE 6 mg/mL

    OSELTAMIVIR PHOSPHATE is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Leading Pharma, LLC. The primary component is OSELTAMIVIR PHOSPHATE.

    Product Information

    NDC 69315-0174
    Product ID 69315-174_4edfa8df-c8f9-4442-8fa0-21c145c64fe1
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name OSELTAMIVIR PHOSPHATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name OSELTAMIVIR PHOSPHATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 6
    Active Ingredient Units mg/mL
    Substance Name OSELTAMIVIR PHOSPHATE
    Labeler Name Leading Pharma, LLC
    Pharmaceutical Class Neuraminidase Inhibitor [EPC], Neuraminidase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA214949
    Listing Certified Through 2025-12-31

    Package

    NDC 69315-0174-60 (69315017460)

    NDC Package Code 69315-174-60
    Billing NDC 69315017460
    Package 60 mL in 1 BOTTLE (69315-174-60)
    Marketing Start Date 2022-06-01
    NDC Exclude Flag N
    Pricing Information N/A